Global Malaria Diagnostics Industry Analysis and Outlook 2020-2025
August 27, 2020 06:53 ET
|
Research and Markets
Dublin, Aug. 27, 2020 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market - Growth, Trends, and Forecast (2020-2025)" report has been added to ResearchAndMarkets.com's offering. The global malaria...
Gazelle® Diagnostic Platform, Designed for Low Resource Settings, Integrates Miniaturized Technologies with AI to Transform Disease Screening and Diagnosis
June 17, 2020 03:01 ET
|
Hemex Health
8-minute, Low-Cost Diagnostic Test for Sickle Cell Disease (SCD) Among First Approved Tests Includes a One-Minute Malaria Test with Solutions for Other Health Priorities to Follow PORTLAND, Ore. and...
PAI Life Science’s Biochemistry Expertise Links with Hemex Health’s Gazelle™ Miniaturized Rapid Diagnostic Platform to Develop Pandemic Test
April 15, 2020 11:00 ET
|
Hemex Health
SEATTLE and PORTLAND, Ore., April 15, 2020 (GLOBE NEWSWIRE) -- Researchers in Seattle and Portland have agreed to collaborate on an urgently needed rapid COVID-19 diagnostic test that can diagnose...
Global Hydroxychloroquine Market Is Expected to Reach 5,549.65 Million by 2027 : Fior Markets
April 10, 2020 05:12 ET
|
Fior Markets
Newark, NJ, April 10, 2020 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, the global hydroxychloroquine market is expected to grow from USD 542.36 million in 2019 and to reach USD...
Co-Diagnostics, Inc. Continues to Execute on International Expansion
October 29, 2019 06:30 ET
|
Co-Diagnostics
Salt Lake City, Oct. 29, 2019 (GLOBE NEWSWIRE) -- Salt Lake City, Utah – October 29, 2019 – Co-Diagnostics, Inc. (Nasdaq: CODX) (the “Company”), a molecular diagnostics company with a unique,...
UVA School of Data Science Leverages Machine Learning to Solve Global Challenges
October 22, 2019 10:46 ET
|
University of Virginia School of Data Science
Charlottesville, Va., Oct. 22, 2019 (GLOBE NEWSWIRE) -- Climate change, global health, and cyber security are just a few of the challenges that researchers at the University of Virginia School of...
GeoVax Announces Reverse Stock Split
May 03, 2019 08:59 ET
|
GeoVax, Inc.
1:500 Reverse Split Effective May 2, 2019;Ticker Symbol Changed to GOVXD for 20 Days ATLANTA, GA, May 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX) today...
GeoVax Provides Product Development and Corporate Update
March 11, 2019 09:00 ET
|
GeoVax, Inc.
ATLANTA, GA, March 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines and immunotherapies using its novel viral vector...
HitGen Launching Initiative to Discover New Medicines to Combat Tuberculosis and Malaria
August 02, 2018 20:00 ET
|
HitGen Ltd.
CHENGDU, China, Aug. 03, 2018 (GLOBE NEWSWIRE) -- HitGen Ltd., a privately held biotech company, announced today a three-year grant from the Bill & Melinda Gates Foundation. The grant will be...
GeoVax to Conduct Partnering Meetings During BIO International Convention June 4-7
May 22, 2018 09:00 ET
|
GeoVax, Inc.
CEO Robert McNally to Speak as part of BIO’s One Health Day Program ATLANTA, GA., May 22, 2018 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human...